⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 26, 2024Journal of the American Geriatrics SocietyOpen Access

Treatment patterns and oncological outcomes of older adults with metastatic prostate cancer in real‐world setting

Mike Wenzel Benedikt Hoeh Nele Wagner Florestan Koll Carolin Siech Clara Humke Thomas Steuber Markus Graefen Derya Tilki Luis Kluth Miriam Traumann Séverine Banek Felix K.‐H. Chun Philipp Mandel

View Full Paper

Ask AI

Bookmark

Share

Abstract

This is the authors' abstract. We don't add key points for this paper.

The landscape of systemic therapies for metastatic hormone-sensitive (mHSPC) and castration resistant prostate cancer (mCRPC) extensively improved within the last decades resulting in a significantly prolonged overall survival. However, subgroup analyses of phase III trials suggest potentially different overall survival outcomes for older adults.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wenzel et al. (2024) studied this question.

synapsesocial.com/papers/68e633a8b6db6435875c5145 https://doi.org/10.1111/jgs.19045

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Contemporary Treatment Patterns and Oncological Outcomes of Metastatic Hormone-sensitive Prostate Cancer and First- to Sixth- line Metastatic Castration-resistant Prostate Cancer Patients2024 · 18 citations
2Treatment Patterns and Survival Outcomes in Korean Patients With Metastatic Hormone-Sensitive Prostate Cancer in a Real-World Setting2025
3Treatment Patterns and Survival Outcomes in Korean Patients With Metastatic Hormone-Sensitive Prostate Cancer in a Real-World Setting2025
4Survival trend in metastatic prostate cancer two decades of real-world data on overall survival from GermanyClinical Trial · 2026 · 3 citations
5Advances in systemic therapies for advanced prostate cancerHuman Clinical Trial · 2026 · 1 citations